| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 349,276 | 298,786 | 336,232 | 390,298 | | Cost of Revenue | 161,711 | 126,352 | 152,508 | 163,870 | | | Gross Profit | 187,565 | 172,434 | 183,724 | 226,428 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 22,364 | 43,159 | 17,035 | 32,300 | | Non Recurring |
-
| 15,486 | 7,316 |
-
| | Others | 123,215 | 114,959 | 104,550 | 112,562 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 41,986 | (1,170) | 54,823 | 81,566 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12,292 | (129,043) | 85,880 | (3,605) | | Earnings Before Interest And Taxes | 52,238 | (143,653) | 151,285 | 67,775 | | Interest Expense | 91,511 | 82,986 | 82,046 | 96,241 | | Income Before Tax | (39,273) | (226,639) | 69,239 | (28,466) | | Income Tax Expense | (3,016) | (53,371) |
-
|
-
| | Minority Interest |
-
| 17,140 | 3,479 | (681) | | | | Net Income From Continuing Ops | (36,257) | (143,858) | 60,448 | (19,675) | | | Non-recurring Events | | Discontinued Operations | 3,688 | 152,029 | 115,351 | 275,714 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (32,569) | 8,171 | 175,799 | 256,039 | | Preferred Stock And Other Adjustments | (5,127) | (13,606) | (12,224) | (13,670) | | | Net Income Applicable To Common Shares | ($37,696) | ($5,435) | $163,575 | $242,369 |
|
0.45% Nasdaq 
0.20%
Income Statement
